Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. 1994

E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
Department of Immunology, Medical School (Charité) Humboldt University of Berlin, Germany.

Human cytomegalovirus (CMV) infection is an important cause of morbidity and mortality in transplant recipients. CMV infection commonly results from the reactivation of a latent infection. Using a set of monoclonal anti-CMV antibodies, we found CMV antigen expression in peripheral blood mononuclear cells (PBMNC), particularly in monocytes, in 312 of 816 samples from 190 allograft recipients. The detection of CMV-IE antigens and CMV-IE DNA in PBMNC indicates that positive cells may represent truly infected cells. The relation between increased cytokine plasma levels (particularly following treatment by pan-T cell antibodies) and the appearance of CMV antigens in PBMNC suggests that cytokines may play an important role in the reversal of CMV latency. This hypothesis is supported by our finding that tumor necrosis factor-alpha (TNF) is able to stimulate the activity of the CMV-IE enhancer/promoter region in the human monocytic cell line, HL-60. The interleukins 1, 2, 3, 4, 6, 8 and 10; transforming growth factor-beta; interferongamma; and granulocyte/macrophage colony-stimulating factor did not show any enhancing effect on the CMV promoter activity. Thus, TNF-alpha seems to play a key role in regulating the balance between latency and reactivation of CMV infection. Inhibition of TNF-alpha release or action may be an alternative strategy for preventing CMV-associated morbidity in allograft recipients.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
January 2000, The Journal of infectious diseases,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
July 2015, Clinics (Sao Paulo, Brazil),
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
December 2006, Transplant infectious disease : an official journal of the Transplantation Society,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
December 1995, Infectious disease clinics of North America,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
February 2002, Hepatobiliary & pancreatic diseases international : HBPD INT,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
January 2008, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
July 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
May 2017, Expert review of respiratory medicine,
E Fietze, and S Prösch, and P Reinke, and J Stein, and W D Döcke, and G Staffa, and S Löning, and S Devaux, and F Emmrich, and R von Baehr
December 1987, Journal of clinical gastroenterology,
Copied contents to your clipboard!